Clinical Trial Update: Glycemic Response to Momordica Charantia in Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the glycemic response to Momordica charantia in type 2 diabetes; the trial status is withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Momordica charantia (Momordica charantia)

Snippet

Sponsor: Services Hospital, Lahore | Conditions: Type 2 Diabetes | Phase 2 | Status: WITHDRAWN